BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38683607)

  • 21. Improved Survival in Patients with Viral Hepatitis-Induced Hepatocellular Carcinoma Undergoing Recommended Abdominal Ultrasound Surveillance in Ontario: A Population-Based Retrospective Cohort Study.
    Thein HH; Campitelli MA; Yeung LT; Zaheen A; Yoshida EM; Earle CC
    PLoS One; 2015; 10(9):e0138907. PubMed ID: 26398404
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Community-based screening for hepatocellular carcinoma in elderly residents in a hepatitis B- and C-endemic area.
    Huang YC; Huang CF; Chang KC; Hung SF; Wang JH; Hung CH; Chen CH; Tseng PL; Kee KM; Yen YH; Tsai PS; Tsai CC; Lu SN
    J Gastroenterol Hepatol; 2011 Jan; 26(1):129-34. PubMed ID: 21175806
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Level of α-fetoprotein predicts mortality among patients with hepatitis C-related hepatocellular carcinoma.
    Tyson GL; Duan Z; Kramer JR; Davila JA; Richardson PA; El-Serag HB
    Clin Gastroenterol Hepatol; 2011 Nov; 9(11):989-94. PubMed ID: 21820396
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatocellular carcinoma screening and surveillance in 2293 chronic hepatitis B patients in an endemic area.
    Ungtrakul T; Mahidol C; Chun-On P; Laohapand C; Siripongsakun S; Worakitsitisatorn A; Vidhayakorn S; Boonchuay W; Dechma J; Sornsamdang G; Soonklang K; Sriprayoon T; Tanwandee T; Auewarakul CU
    World J Gastroenterol; 2016 Sep; 22(34):7806-12. PubMed ID: 27678364
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inadequate Hepatocellular Carcinoma Screening in Patients With Nonalcoholic Steatohepatitis Cirrhosis.
    Aby E; Phan J; Truong E; Grotts J; Saab S
    J Clin Gastroenterol; 2019 Feb; 53(2):142-146. PubMed ID: 29912761
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association Between Noninvasive Fibrosis Markers and Postoperative Mortality After Hepatectomy for Hepatocellular Carcinoma.
    Maegawa FB; Shehorn L; Aziz H; Kettelle J; Jie T; Riall TS
    JAMA Netw Open; 2019 Jan; 2(1):e187142. PubMed ID: 30657533
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost-effectiveness analysis of hepatocellular carcinoma screening by combinations of ultrasound and alpha-fetoprotein among Alaska Native people, 1983-2012.
    Gounder PP; Bulkow LR; Meltzer MI; Bruce MG; Hennessy TW; Snowball M; Spradling PR; Adhikari BB; McMahon BJ
    Int J Circumpolar Health; 2016; 75():31115. PubMed ID: 27197711
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surveillance for Hepatocellular Carcinoma Reduces Mortality: an Inverse Probability of Treatment Weighted Analysis.
    Chaiteerakij R; Chattieng P; Choi J; Pinchareon N; Thanapirom K; Geratikornsupuk N
    Ann Hepatol; 2017; 16(3):421-429. PubMed ID: 28425412
    [TBL] [Abstract][Full Text] [Related]  

  • 29. GALAD demonstrates high sensitivity for HCC surveillance in a cohort of patients with cirrhosis.
    Singal AG; Tayob N; Mehta A; Marrero JA; El-Serag H; Jin Q; Saenz de Viteri C; Fobar A; Parikh ND
    Hepatology; 2022 Mar; 75(3):541-549. PubMed ID: 34618932
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatocellular Carcinoma Demonstrates Heterogeneous Growth Patterns in a Multicenter Cohort of Patients With Cirrhosis.
    Rich NE; John BV; Parikh ND; Rowe I; Mehta N; Khatri G; Thomas SM; Anis M; Mendiratta-Lala M; Hernandez C; Odewole M; Sundaram LT; Konjeti VR; Shetty S; Shah T; Zhu H; Yopp AC; Hoshida Y; Yao FY; Marrero JA; Singal AG
    Hepatology; 2020 Nov; 72(5):1654-1665. PubMed ID: 32017165
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surveillance for hepatocellular carcinoma improves survival in Asian-American patients with hepatitis B: results from a community-based clinic.
    Tong MJ; Sun HE; Hsien C; Lu DS
    Dig Dis Sci; 2010 Mar; 55(3):826-35. PubMed ID: 19960258
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Continued value of the serum alpha-fetoprotein test in surveilling at-risk populations for hepatocellular carcinoma.
    An J; Kim HI; Chang S; Shim JH
    PLoS One; 2020; 15(8):e0238078. PubMed ID: 32845895
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness of AFP and ultrasound tests on hepatocellular carcinoma mortality in HCV-infected patients in the USA.
    El-Serag HB; Kramer JR; Chen GJ; Duan Z; Richardson PA; Davila JA
    Gut; 2011 Jul; 60(7):992-7. PubMed ID: 21257990
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alpha-fetoprotein and/or liver ultrasonography for liver cancer screening in patients with chronic hepatitis B.
    Wun YT; Dickinson JA
    Cochrane Database Syst Rev; 2003; (2):CD002799. PubMed ID: 12804438
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alpha-Fetoprotein Detection of Hepatocellular Carcinoma Leads to a Standardized Analysis of Dynamic AFP to Improve Screening Based Detection.
    Bird TG; Dimitropoulou P; Turner RM; Jenks SJ; Cusack P; Hey S; Blunsum A; Kelly S; Sturgeon C; Hayes PC; Bird SM
    PLoS One; 2016; 11(6):e0156801. PubMed ID: 27308823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Abdominal ultrasound and alpha-foetoprotein for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease.
    Colli A; Nadarevic T; Miletic D; Giljaca V; Fraquelli M; Štimac D; Casazza G
    Cochrane Database Syst Rev; 2021 Apr; 4(4):CD013346. PubMed ID: 33855699
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estimate of hepatocellular carcinoma incidence in patients with alcoholic cirrhosis.
    Ganne-Carrié N; Chaffaut C; Bourcier V; Archambeaud I; Perarnau JM; Oberti F; Roulot D; Moreno C; Louvet A; Dao T; Moirand R; Goria O; Nguyen-Khac E; Carbonell N; Antonini T; Pol S; de Ledinghen V; Ozenne V; Henrion J; Péron JM; Tran A; Perlemuter G; Amiot X; Zarski JP; Beaugrand M; Chevret S;
    J Hepatol; 2018 Dec; 69(6):1274-1283. PubMed ID: 30092234
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early detection, curative treatment, and survival rates for hepatocellular carcinoma surveillance in patients with cirrhosis: a meta-analysis.
    Singal AG; Pillai A; Tiro J
    PLoS Med; 2014 Apr; 11(4):e1001624. PubMed ID: 24691105
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ten-Year Outcomes of Liver Transplant and Downstaging for Hepatocellular Carcinoma.
    Tabrizian P; Holzner ML; Mehta N; Halazun K; Agopian VG; Yao F; Busuttil RW; Roberts J; Emond JC; Samstein B; Brown RS; Najjar M; Chapman WC; Doyle MM; Florman SS; Schwartz ME; Llovet JM
    JAMA Surg; 2022 Sep; 157(9):779-788. PubMed ID: 35857294
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatocellular carcinoma is diagnosed at a later stage in alcoholic patients: Results of a prospective, nationwide study.
    Costentin CE; Mourad A; Lahmek P; Causse X; Pariente A; Hagège H; Dobrin AS; Becker C; Marks B; Bader R; Condat B; Héluwaert F; Seitz JF; Lesgourgues B; Denis J; Deuffic-Burban S; Rosa I; Decaens T;
    Cancer; 2018 May; 124(9):1964-1972. PubMed ID: 29589878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.